Zefeng Xuan

446 total citations
18 papers, 296 citations indexed

About

Zefeng Xuan is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Zefeng Xuan has authored 18 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Surgery. Recurrent topics in Zefeng Xuan's work include Drug Transport and Resistance Mechanisms (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Epigenetics and DNA Methylation (3 papers). Zefeng Xuan is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Epigenetics and DNA Methylation (3 papers). Zefeng Xuan collaborates with scholars based in China and Madagascar. Zefeng Xuan's co-authors include Penghong Song, Shusen Zheng, Wenfeng Song, Zequn Li, Long Zhao, Guangyuan Song, Yongchao Zhao, Cheng Jin, Haiyang Xie and Biguang Tuo and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Zefeng Xuan

17 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zefeng Xuan China	11	211	84	67	49	41	18	296
Shaohan Wu China	10	190 0.9×	109 1.3×	99 1.5×	42 0.9×	39 1.0×	20	320
Longci Sun China	9	197 0.9×	127 1.5×	53 0.8×	71 1.4×	29 0.7×	17	327
Mingdian Lu China	9	198 0.9×	101 1.2×	45 0.7×	50 1.0×	15 0.4×	15	271
Atsutaka Masuda Japan	9	142 0.7×	92 1.1×	85 1.3×	51 1.0×	24 0.6×	19	279
Yunhong Tian China	10	123 0.6×	77 0.9×	106 1.6×	76 1.6×	77 1.9×	29	307
Chongyu Zhao China	7	162 0.8×	115 1.4×	82 1.2×	63 1.3×	60 1.5×	23	298
Wei Wen China	11	179 0.8×	127 1.5×	90 1.3×	48 1.0×	60 1.5×	25	350
Feiye Liu China	9	213 1.0×	148 1.8×	44 0.7×	23 0.5×	18 0.4×	13	294
Srikant Ambatipudi India	10	250 1.2×	102 1.2×	77 1.1×	54 1.1×	33 0.8×	17	380

Countries citing papers authored by Zefeng Xuan

Since Specialization

Citations

This map shows the geographic impact of Zefeng Xuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zefeng Xuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zefeng Xuan more than expected).

Fields of papers citing papers by Zefeng Xuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zefeng Xuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zefeng Xuan. The network helps show where Zefeng Xuan may publish in the future.

Co-authorship network of co-authors of Zefeng Xuan

This figure shows the co-authorship network connecting the top 25 collaborators of Zefeng Xuan. A scholar is included among the top collaborators of Zefeng Xuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zefeng Xuan. Zefeng Xuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Qiu, Qiongzi, Wenfeng Song, Shiyu Zhang, et al.. (2025). Comprehensive multi-omics analyses expose a precision therapy strategy that targets replication stress in hepatocellular carcinoma using WEE1 inhibition. Journal of Advanced Research. 78. 497–515. 2 indexed citations

Zhang, Zhijun, Bajin Wei, Zhikun Liu, et al.. (2024). Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection. Hepatobiliary & pancreatic diseases international. 24(3). 269–276.

Li, Zequn, Hao Wu, Wenfeng Song, et al.. (2023). FXR Maintains the Intestinal Barrier and Stemness by Regulating CYP11A1-Mediated Corticosterone Synthesis in Biliary Obstruction Diseases. International Journal of Molecular Sciences. 24(17). 13494–13494. 5 indexed citations

Chen, Jian, Zequn Li, Wenfeng Song, et al.. (2022). Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity. Oncogene. 41(22). 3118–3130. 23 indexed citations

Xuan, Zefeng, et al.. (2020). How DNA methylation affects the Warburg effect. International Journal of Biological Sciences. 16(12). 2029–2041. 29 indexed citations

Song, Guangyuan, Zefeng Xuan, Long Zhao, et al.. (2020). Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma. Theranostics. 11(5). 2318–2333. 29 indexed citations

Zhang, Shiyu, Zefeng Xuan, Liang Zhang, et al.. (2020). Splenic marginal zone lymphoma: a case report and literature review. World Journal of Surgical Oncology. 18(1). 259–259. 3 indexed citations

Li, Zequn, Zefeng Xuan, Jian Chen, et al.. (2020). Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer. International Journal of Oncology. 57(1). 161–170. 10 indexed citations

Zhao, Long, Zefeng Xuan, Wenfeng Song, et al.. (2020). A novel role for farnesoid X receptor in the bile acid‐mediated intestinal glucose homeostasis. Journal of Cellular and Molecular Medicine. 24(21). 12848–12861. 19 indexed citations

10.

Xuan, Zefeng, Wenfeng Song, Hao Chen, et al.. (2020). EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation. Oncogene. 40(1). 163–176. 19 indexed citations

11.

Xuan, Zefeng, Long Zhao, Zequn Li, et al.. (2020). EPS8L3 promotes hepatocellular carcinoma proliferation and metastasis by modulating EGFR dimerization and internalization.. PubMed. 10(1). 60–77. 8 indexed citations

12.

Chen, Hao, Jun Chen, Long Zhao, et al.. (2019). CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma. Journal of Cancer. 10(8). 1846–1854. 47 indexed citations

13.

Chen, Jun, Zequn Li, Jian Chen, et al.. (2019). Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21. Clinical & Translational Oncology. 22(3). 392–400. 12 indexed citations

14.

Song, Wenfeng, Jian Chen, Hao Chen, et al.. (2019). The potassium channel KCa3.1 promotes cell proliferation by activating SKP2 and metastasis through the EMT pathway in hepatocellular carcinoma. International Journal of Cancer. 145(2). 503–516. 39 indexed citations

15.

Chen, Jian, Wenfeng Song, Zequn Li, et al.. (2018). Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation. Biochemical and Biophysical Research Communications. 499(3). 433–440. 14 indexed citations

16.

Xuan, Zefeng, Jian Chen, Penghong Song, et al.. (2018). Management of intrahepatic splenosis:a case report and review of the literature. World Journal of Surgical Oncology. 16(1). 119–119. 14 indexed citations

17.

Song, Penghong, Wenfeng Song, Hao Chen, et al.. (2017). KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma. Journal of Cancer. 8(9). 1568–1578. 17 indexed citations

18.

Chen, Hao, Zefeng Xuan, Wenfeng Song, et al.. (2016). Bile deficiency induces changes in intestinal glucose absorption in mice. Surgery. 160(6). 1496–1507. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact